Page last updated: 2024-08-23

nitazoxanide and Disease Models, Animal

nitazoxanide has been researched along with Disease Models, Animal in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (25.93)	29.6817
2010's	14 (51.85)	24.3611
2020's	6 (22.22)	2.80

Authors

Authors	Studies
Chong, CR; Downey, AS; Graczyk, TK; Sullivan, DJ	1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1
Che, X; Fan, G; Gong, F; Huang, Y; Jia, K; Li, X; Lu, H; Shen, T; Wang, X; Xu, Z; Zhang, J	1
Azam, A; Dwivedi, S; Kausar, S; Khan, W	1
de Lima, NF; Lino Júnior, RS; Picanço, GA; Sampaio, GA; Vinaud, MC; Zago, LV	1
Cicka, D; Sukhatme, VP	1
Abdel Kader, A; El Amir, A; Farid, A; Madbouly, N; Rabee, I	1
Beamer, G; Campbell, MA; Girouard, D; Harwood, M; Lee, S; Meyers, MJ; Tzipori, S	1
Bartelt, LA; Bolick, DT; Guerrant, RL; Hoffman, PS; Huston, CD; Kolling, GL; Stebbins, E	1
El Ghaffar, AEA; El-Kowrany, SI; Gamea, GAM; Mady, RF; Shoheib, ZS	1
Chen, J; Fan, L; Guan, XW; Li, J; Lu, J; Lv, JL; Mao, F; Qiu, XX; Ren, J; Shen, X; Wang, JY; Ye, JM; Zhao, YH; Zhu, J; Zhu, ZY	1
Bassaganya-Riera, J; Bolick, DT; Guerrant, RL; Hontecillas, R; Nataro, JP; Roche, JK	1
Favennec, L; François, A; Gargala, G; Rossignol, JF	1
Bodapati, S; Fan, A; Fan-Minogue, H; Felsher, DW; Gambhir, SS; Massoud, TF; Paulmurugan, R; Solow-Cordero, D	1
Deng, X; Li, B; Li, S; Ma, Z; Qiu, Y; Shao, D; Shi, Z; Wang, X; Wei, J; Xue, F; Zhang, K	1
Abdollahi, M; Ganjali, Z; Javan, MR; Khalseh, R; Khani, M; Ramroodi, N; Ravan, H; Sanadgol, E; Sanadgol, N	1
Delgado-Enciso, I; Dobrovinskaya, O; Espinoza-Gómez, F; López-Lemus, UA; Melnikov, V; Pimientel-Rodrigez, V; Rodriguez-Hernández, A; Rueda-Valdovinos, G; Valle-Reyes, JS; Wookee-Zea, C	1
Costa, LB; Freire, RS; Guerrant, RL; Hoffman, PS; JohnBull, EA; Lima, AA; Oriá, RB; Reeves, JT; Roche, JK; Sevilleja, JE; Warren, CA	1
Boykin, D; Debache, K; Guionaud, C; Hemphill, A; Kropf, C; Stephens, CE	1
Ballard, TE; Guerrant, RL; Hoffman, PS; Kennedy, A; Kolling, GL; Macdonald, TL; Olekhnovich, I; Riggins, M; van Opstal, E; Wang, X; Warren, CA; Warthan, M	1
Abdou, AG; Afifi, AF; Elnaidany, NF; Harba, NM	1
Agnamey, P; Ballet, JJ; Brasseur, P; Favennec, L; Leméteil, D; Li, X; Rossignol, JF	1
Fonseca-Salamanca, F; Martínez-Fernández, AR; Martínez-Grueiro, MM	1
Moustafa, MA	1
Delgado, OM; Fernandez, G; Ramirez, O; Rodriguez-Morales, AJ; Romero, J; Silva, S	1
Al-Malki, JS; Sanad, MM	1
McVay, CS; Rolfe, RD	1

Other Studies

27 other study(ies) available for nitazoxanide and Disease Models, Animal

Article	Year
Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Animals; Animals, Newborn; Antiprotozoal Agents; Cell Line; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Pyrvinium Compounds; Treatment Outcome	2008
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020
Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:20 Topics: Animals; Animals, Genetically Modified; Apoptosis; Cardiotoxicity; Computational Biology; Disease Models, Animal; Disease Susceptibility; Embryo, Nonmammalian; Gene Expression Profiling; Gene Ontology; Heart Injuries; Myocytes, Cardiac; Nitro Compounds; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Thiazoles; Zebrafish	2021
Antifilarial effect of nanocomposite of silver nanoparticles with nitazoxanide against the microfilariae of Setaria cervi-infected albino rats. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:8 Topics: Animals; Diethylcarbamazine; Disease Models, Animal; Drug Compounding; Drug Synergism; Filaricides; Host-Parasite Interactions; Male; Metal Nanoparticles; Nanocomposites; Nitro Compounds; Rats; Setaria Nematode; Setariasis; Silver; Thiazoles	2020
Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole/nitazoxanide combination. Parasitology, 2020, Volume: 147, Issue:7 Topics: Albendazole; Animals; Anticestodal Agents; Disease Models, Animal; Drug Combinations; Female; Mice; Mice, Inbred BALB C; Neurocysticercosis; Nitro Compounds; Taenia; Thiazoles	2020
Available drugs and supplements for rapid deployment for treatment of COVID-19. Journal of molecular cell biology, 2021, 07-06, Volume: 13, Issue:3 Topics: Adenosine Monophosphate; Alanine; Animals; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Repositioning; Flavonoids; Humans; Mice; Nitro Compounds; Pharmaceutical Preparations; SARS-CoV-2; Small Molecule Libraries; Teicoplanin; Thiazoles	2021
The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model. Journal of medical microbiology, 2021, Volume: 70, Issue:3 Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ileum; Immunocompromised Host; Immunomodulation; Male; Metronidazole; Mice; Nitro Compounds; Parasite Load; Thiazoles	2021
The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis. PloS one, 2017, Volume: 12, Issue:10 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Disease Models, Animal; Drug Therapy, Combination; Nitro Compounds; Sus scrofa; Swine; Thiazoles; Treatment Outcome	2017
Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:12 Topics: Animals; Antiprotozoal Agents; Benzamides; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Mice, Inbred C57BL; Nitro Compounds; Pyruvate Synthase; Thiazoles; Weight Loss	2018
Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis. Acta tropica, 2019, Volume: 195 Topics: Acute Disease; Animals; Antiparasitic Agents; Chronic Disease; Disease Models, Animal; Mice; Nitro Compounds; Thiazoles; Toxoplasma; Toxoplasmosis	2019
Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:10 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antiparasitic Agents; Cells, Cultured; Disease Models, Animal; Humans; Learning; Memory Disorders; Mice; Nitro Compounds; Thiazoles	2019
Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 6 Topics: Animals; Biofilms; Colon; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Feces; Humans; Male; Malnutrition; Mice; Mice, Inbred C57BL; Nitro Compounds; Thiazoles; Virulence; Virulence Factors; Weaning	2013
Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus). Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Gerbillinae; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Nitro Compounds; Thiazoles; Treatment Outcome	2013
A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. Molecular cancer therapeutics, 2013, Volume: 12, Issue:9 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Heterografts; High-Throughput Screening Assays; Humans; Mice; Mice, Nude; Molecular Imaging; Neoplasm Transplantation; Nitro Compounds; Proto-Oncogene Proteins c-myc; Thiazoles	2013
Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model. Virology journal, 2014, Jan-23, Volume: 11 Topics: Animals; Antiviral Agents; Cell Line; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis Virus, Japanese; Encephalitis, Japanese; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nitro Compounds; Survival Analysis; Thiazoles; Treatment Outcome; Viral Load; Virus Replication	2014
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis. Immunological investigations, 2015, Volume: 44, Issue:7 Topics: Animals; Blood-Brain Barrier; CD11b Antigen; Cell Movement; Cerebral Cortex; Cytokines; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Inflammation Mediators; Integrin alpha4beta1; Leukocyte Common Antigens; Leukocytes; Male; Mice; Monocytes; Multiple Sclerosis; Nitro Compounds; Oligopeptides; Permeability; RNA, Messenger; Thiazoles	2015
Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model. Experimental parasitology, 2017, Volume: 172 Topics: Animals; Chagas Disease; Disease Models, Animal; Heart; Male; Mice, Inbred BALB C; Muscle, Striated; Myocardium; Nitro Compounds; Parasitemia; Thiazoles; Trypanocidal Agents; Trypanosoma cruzi	2017
Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model. The Journal of parasitology, 2011, Volume: 97, Issue:6 Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; DNA, Protozoan; Feces; Female; Ileum; Intestinal Mucosa; Malnutrition; Mice; Mice, Inbred C57BL; Nitro Compounds; RNA, Messenger; Thiazoles; Toll-Like Receptors; Weaning; Weight Gain	2011
Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide. Experimental parasitology, 2011, Volume: 129, Issue:2 Topics: Administration, Oral; Amidines; Animals; Body Weight; Brain; Cell Line; Chlorocebus aethiops; Coccidiosis; Coccidiostats; Disease Models, Animal; DNA, Protozoan; Female; Fibroblasts; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Neospora; Nitro Compounds; Polymerase Chain Reaction; Pyridines; Random Allocation; Thiazoles; Vero Cells	2011
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzamides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enzyme Inhibitors; Fidaxomicin; Mice; Microbial Sensitivity Tests; Nitro Compounds; Pyruvate Synthase; Thiazoles; Treatment Outcome; Vancomycin	2012
Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:8 Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Cyclin D1; Disease Models, Animal; Female; Immunocompromised Host; Intestinal Mucosa; Intestines; Liver; Mice; Nitro Compounds; Oocysts; Thiazoles	2013
Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia parasitologica, 2003, Volume: 50, Issue:1 Topics: Adenosine; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Feces; Immunocompromised Host; Male; Nitro Compounds; Parasite Egg Count; Paromomycin; Rats; Rats, Sprague-Dawley; Thiazoles	2003
Nematocidal activity of nitazoxanide in laboratory models. Parasitology research, 2003, Volume: 91, Issue:4 Topics: Animals; Antinematodal Agents; Antiparasitic Agents; Biological Assay; Caenorhabditis elegans; Disease Models, Animal; Dose-Response Relationship, Drug; Heligmosomatoidea; Mice; Nematoda; Nitro Compounds; Parasitic Diseases, Animal; Thiazoles; Trichinella spiralis; Trichinellosis	2003
Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis. Journal of the Egyptian Society of Parasitology, 2003, Volume: 33, Issue:2 Topics: Animals; Animals, Suckling; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Immunocompromised Host; Mice; Nitro Compounds; Thiazoles; Wheat Germ Agglutinins	2003
Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model. International journal of antimicrobial agents, 2008, Volume: 31, Issue:2 Topics: Animals; Disease Models, Animal; Mice; Nitro Compounds; Thiazoles; Toxocara canis; Toxocariasis	2008
Immunochemotherapy for cryptosporidiosis in immunosuppressed mouse model. Journal of the Egyptian Society of Parasitology, 2007, Volume: 37, Issue:3 Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunotherapy; Interferon-gamma; Life Cycle Stages; Mice; Nitro Compounds; Oocysts; Parasite Egg Count; Paromomycin; Random Allocation; Thiazoles; Time Factors; Treatment Outcome	2007
In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9 Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin	2000